Thailand Recommerce Market Intelligence Databook - 60+ KPIs, Market Size, Share & Forecast by Channel, Category & Consumer Segment - Q2 2025 Update
DUBLIN--(BUSINESS WIRE)--Jun 27, 2025--
The 'Thailand Recommerce Market Intelligence Databook - 60+ KPIs, Market Size, Share & Forecast by Channel, Category & Consumer Segment - Q2 2025 Update' has been added to ResearchAndMarkets.com's offering.
The recommerce market in Thailand is set to witness significant growth, with an annual increase of 14.5% anticipated, propelling market value to USD 1.79 billion by 2025. Driven by a robust CAGR of 17.8% between 2020 and 2024, this segment is expected to maintain momentum through a CAGR of 12.2% from 2025 to 2029, reaching a projected valuation of USD 2.84 billion by the end of 2029.
This analysis offers a comprehensive, data-centric examination of Thailand's recommerce landscape, pinpointing market opportunities and risks within consumer segments and across various sales channels and resale formats. Highlighting over 60 KPIs, the report provides an in-depth understanding of market dynamics.
The recommerce sector in Thailand is segmented into channels like C2C and B2C and through sales models such as resale, rental, and refurbishment. It extends across platform types and retail categories including electronics, apparel, and home goods. Further insights into consumer behavior, device preferences, and digital engagement outline city-level market penetration from Tier 1 to Tier 3 cities.
Scope The report encompasses over 40 tables and 55 charts, offering forecasts and performance indicators tied to transaction value, volume, and market share trends from 2020 to 2029. It covers key market dimensions:
Reasons to buy
Key Attributes:
For more information about this report visit https://www.researchandmarkets.com/r/svf2fj
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250627876887/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD: THAILAND SOUTHEAST ASIA ASIA PACIFIC
INDUSTRY KEYWORD: RETAIL OTHER RETAIL
SOURCE: Research and Markets
Copyright Business Wire 2025.
PUB: 06/27/2025 10:50 AM/DISC: 06/27/2025 10:50 AM
http://www.businesswire.com/news/home/20250627876887/en
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
6 hours ago
- Business Upturn
Rubber Processing Chemicals Market to Surpass USD 8.89 billion by 2032
Austin, June 29, 2025 (GLOBE NEWSWIRE) — The Rubber Processing Chemicals Market Size was valued at USD 6.14 billion in 2024 and is expected to reach USD 8.89 billion by 2032, growing at a CAGR of 4.72% over the forecast period of 2025-2032. Growing demand for sustainable and high-performance solutions drives the adoption of advanced rubber processing chemicals across key industries The rubber processing chemicals market is gaining momentum due to rising industrialization, automotive output, and sustainability-focused innovations. Regulatory bodies like the U.S. EPA and organizations such as the RMA and CSB are encouraging safer chemical usage and highlighting rising tire production. Companies like Lanxess and Lubrizol are introducing advanced anti-degradants and accelerators to meet evolving performance and compliance standards. The expanding use of flame retardants and processing aids in automotive, industrial, and consumer goods segments is further supporting long-term market growth and transformation. Download PDF Sample of Rubber Processing Chemicals Market @ The U.S. Rubber Processing Chemicals market is valued at USD 0.845 billion in 2024 and is projected to reach a value of USD 1.35 billion with a CAGR of 6.10% during the forecast period of 2025-2032. The U.S. Rubber Processing Chemicals Market is expanding due to increased automotive production, rising demand for industrial rubber goods, and EPA-driven environmental regulations. Continuous innovation by companies like Eastman Chemical and a steady rise in tire manufacturing, as reported by the Rubber Manufacturers Association, further support market growth and product development. Key Players: Lanxess AG Eastman Chemical Company Solvay S.A. Arkema S.A. BASF SE Akzo Nobel N.V. China Petroleum & Chemical Corporation (Sinopec) Sumitomo Chemical Co., Ltd. Emerald Performance Materials LLC Behn Meyer Group Rubber Processing Chemicals Market Report Scope: Report Attributes Details Market Size in 2024 USD 6.14 Billion Market Size by 2032 USD 8.89 Billion CAGR CAGR of 4.72% From 2025 to 2032 Base Year 2024 Forecast Period 2025-2032 Historical Data 2021-2023 Report Scope & Coverage Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook Key Drivers • Growing Demand for High-Performance and Specialty Rubber drives the Market Growth. If You Need Any Customization on Rubber Processing Chemicals Market Report, Inquire Now @ By Product, the Anti-degradants dominated the Rubber Processing Chemicals Market in 2024 with a 48% Market Share. The dominance is due to the essential role of accelerators in enhancing vulcanization speed and improving rubber product durability. Rising demand from automotive and industrial applications has prompted major producers like Lanxess and Lubrizol to expand eco-friendly product lines. Their focus on regulatory compliance and high-performance formulations, such as Lubrizol's 2023 thiuram launch, supports broader adoption. Additionally, their use in conveyor belts and hoses adds further momentum, making accelerators a preferred choice across global manufacturing environments. By Application, the Tire dominated the Rubber Processing Chemicals Market in 2024 with a 56% Market Share. The dominance is due to the high consumption of rubber processing chemicals in tire manufacturing, fueled by increased automotive production and replacement cycles. Tire makers like Bridgestone and Michelin are pushing innovation by incorporating bio-based and custom chemical solutions to meet sustainability goals. Rubber chemicals like anti-degradants and flame retardants play a key role in extending tire life and performance. The tire segment remains the most critical consumer due to its scale, frequency of replacement, and regulatory requirements. By Region, Asia Pacific dominated the Rubber Processing Chemicals Market in 2024, Holding a 52% Market Share. The dominance is due to Asia Pacific's position as a manufacturing hub for both automotive and rubber goods, especially in China, India, and Southeast Asia. A 9% rise in China's tire production in 2023, as reported by its Ministry of Industry and IT, has propelled chemical demand. Expanding infrastructure and construction activities further boost the consumption of non-tire rubber products. Additionally, stricter eco-regulations in Japan and South Korea have led to increased use of safer, compliant rubber processing additives across the region. Recent Developments • In January 2025, MIT CSAIL unveiled 'Thermochromorph,' a printing method using thermochromic inks to create temperature-responsive visuals for adaptive design and artistic applications. • In February 2025, OliKrom introduced thermochromic labels for pharma use, changing color upon oxidation to indicate vaccine spoilage, improving safety, and reducing medical waste. Buy Full Research Report on Rubber Processing Chemicals Market 2025-2032 @ About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Business Upturn
6 hours ago
- Business Upturn
Viscosupplementation Market Size to Reach USD 11.37 Billion by 2032 Owing to Rising Geriatric Population and Growing Osteoarthritis Incidence
Austin, June 29, 2025 (GLOBE NEWSWIRE) — Viscosupplementation Market Size & Growth Analysis: 'According to SNS Insider, the global Viscosupplementation Market was valued at USD 5.48 billion in 2024 and is expected to reach USD 11.37 billion by 2032, expanding at a CAGR of 9.56% over the forecast period of 2025–2032.' Growing need for minimally invasive osteoarthritis treatment, favourable reimbursement policies, and increasing incidence of knee disorders would contribute to the adoption of viscosupplementation worldwide. Get a Sample Report of Viscosupplementation Market@ U.S. viscosupplementation market was valued at USD 1.21 billion in the year 2024 and is estimated to reach USD 2.50 billion by the year 2032. This expansion is a result of growing FDA approvals, strong presence of key manufacturers, and high adoption of three-injection therapy for osteoarthritis patients in both orthopedic clinics and ambulatory surgical centers. Market Overview The viscosupplementation market is growing leaps and bounds as a result of the increasing population with osteoarthritis, especially in the older age segment across the world. As awareness of alternative pain treatments, e.g., minimally invasive, continues to increase, so does the request for hyaluronic acid (HA) injections that are able to restore the viscosity of the damaged synovial fluid in the joints. The treatment has been widely adopted because it is associated with short recovery time, fewer side effects, and more patient satisfaction. In addition, the feasibility of having single- or multiple-injection regimens available facilitates individual treatment planning according to patient preference and extent of disease. North America dominates the market on account of well-established healthcare infrastructure, increasing adoption across the region, and continued development. At the same time, Asia Pacific is set to be the fastest-growing region on account of the rising accessibility to healthcare, the growing number of orthopedic procedures, and increasing awareness of viscosupplementation. Efforts by the governments of countries like Japan, China, and India to enhance geriatric care are also driving growth in the region. Major Players Analysis Listed in this Report are: DePuy Synthes Fidia Farmaceutici S.p.A Sanofi Smith & Nephew PLC Anika Therapeutics, Inc. Seikagaku Corp. Zimmer Biomet Ferring Pharmaceuticals B.V. Lifecore Biomedical LG Life Sciences Ltd. Roche Ltd. Viscosupplementation Market Report Scope Report Attributes Details Market Size in 2023 US$ 5.48 billion Market Size by 2032 US$ 11.37 billion CAGR (2024–2032) 9.56% U.S. Market 2023 USD 1.21 billion U.S. Forecast by 2032 USD 2.50 billion Base Year 2023 Forecast Period 2024–2032 Key Regional Coverage North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) Segment Analysis By Product: The three-injection viscosupplementation segment held the largest market share in 2023, accounting for 42%. This dominance is attributed to its proven long-term efficacy in moderate-to-severe osteoarthritis cases, offering sustained pain relief and improved mobility. Physicians widely prefer this format due to its extensive clinical validation and familiarity. Meanwhile, the single-injection segment is the fastest-growing product type. Its rapid adoption is driven by increased patient compliance, reduced clinic visits, and lower procedural costs. These benefits are especially appealing in outpatient and resource-constrained settings. By End-Use: In 2023, orthopedic clinics and ambulatory surgical centers (ASCs) led the market, contributing 63% of the overall revenue. The rise of outpatient care models, availability of advanced orthopedic expertise, and focus on cost-effective joint pain management have supported this segment's dominance. Conversely, hospitals are the fastest-growing end-use segment due to the rise in inpatient osteoarthritis treatment, complex case management, and integration of viscosupplementation into broader rehabilitation programs, particularly for elderly and comorbid patients. For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@ Viscosupplementation Market Segmentation By Product Three Injection Single Injection Five Injection By End-use Hospitals Orthopedic Clinics/ASCs Regional Analysis North America held the largest share of the viscosupplementation market in 2024, driven by a high osteoarthritis patient base, favorable insurance coverage, and strong regulatory backing for HA-based injectables. The U.S. continues to dominate due to established clinical protocols and patient preference for minimally invasive alternatives. Asia Pacific is the fastest-growing regional market, propelled by increasing healthcare expenditure, improving patient awareness, and rapid urbanization. Growing demand in China, Japan, and India is further stimulated by efforts to reduce surgical interventions through conservative treatment options. Recent Developments In January 2024, Zimmer Biomet launched a new three-injection viscosupplementation product in select global markets targeting moderate-stage osteoarthritis. In February 2024, Sanofi announced the rollout of its improved formulation of hyaluronic acid injections across Europe, aimed at extending joint relief duration. In March 2024, the U.S. FDA approved multiple new single- and three-injection HA-based viscosupplementation products, enhancing treatment availability. In April 2024, Seikagaku Corporation reported over 2 million units of viscosupplementation products distributed globally during the first half of 2024. Table of Contents – Major Key Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 6. Competitive Landscape 7. Viscosupplementation Market by Product 8. Viscosupplementation Market by End-use 9. Regional Analysis 10. Company Profiles 11. Use Cases and Best Practices 12. Conclusion Buy a Single-User PDF of Viscosupplementation Market Analysis & Outlook Report 2024-2032@ About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Business Upturn
6 hours ago
- Business Upturn
Vaccine Adjuvants Market to Reach USD 5.43 Billion by 2032 Due to Increasing Demand for Enhanced Vaccine Efficacy and Global Immunization Programs
Austin, June 29, 2025 (GLOBE NEWSWIRE) — Vaccine Adjuvants Market Size & Growth Analysis: According to SNS Insider, the Vaccine Adjuvants Market was valued at USD 3.83 billion in 2024 and is projected to reach USD 5.43 billion by 2032, expanding at a CAGR of 4.47% during the forecast period of 2025–2032. This growth is strongly linked to the increasing focus on vaccine efficacy enhancement, global immunization strategies, and investment in next-generation vaccine technologies. The U.S. vaccine adjuvants market was valued at USD 1.25 billion in 2024 and is estimated to reach USD 1.76 billion by 2032, capturing 86% of the North America vaccine adjuvants market share in 2023. This is well supported by an excellent R&D infrastructure, strong vaccine pipelines, and quick uptake of novel adjuvant systems into commercially available vaccines. Get a Sample Report of Vaccine Adjuvants Market@ Adjuvants play a pivotal role in boosting immune responses, improving vaccine durability, and enabling dose-sparing strategies. With the global health ecosystem emphasizing prevention over treatment, vaccine adjuvants are emerging as indispensable components of both human and veterinary vaccines. Their relevance continues to grow in the fight against emerging infectious diseases, chronic infections, and global pandemics. Market Overview Vaccine adjuvants are agents added to vaccines to enhance their immunogenicity. As newer, more targeted vaccine formulations gain traction, adjuvants are critical for amplifying immune responses, especially in elderly and immunocompromised populations. With support from entities like the WHO, NIH, and major pharmaceutical firms, vaccine adjuvant technologies are evolving rapidly. The market is characterized by increased collaborations between biotech startups, government health agencies, and pharmaceutical manufacturers. Innovations in lipid-based delivery systems, particulate formulations, and immunostimulatory compounds are pushing boundaries in vaccine R&D. The race to combat both existing and novel pathogens is fueling consistent demand. Major Players Analysis Listed in this Report are: CSL Limited GlaxoSmithKline plc Phibro Animal Health Corporation Novavax Inc. Adjuvance Technologies Inc. Agenus Inc. InvivoGen Brenntag Biosector SPI Pharma Hawaii Biotech Inc. Aurorium Dynavax Technologies Corporation Vaccine Adjuvants Market Report Scope Report Attributes Details Market Size in 2024 US$ 3.83 billion Market Size by 2032 US$ 5.43 billion CAGR (2025–2032) 4.47% U.S. Market 2024 USD 1.25 billion U.S. Forecast by 2032 USD 1.76 billion Base Year 2024 Forecast Period 2025–2032 Key Regional Coverage North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) Segment Analysis By Type: Particulate adjuvants accounted for the largest market segment in the vaccine adjuvants market in 2023; these adjuvants had a 31% market share. This domain is claimed to be the most superior portion concerning antigen delivery, stimulation of the immune system, stability, and both viral and bacterial vaccines. By Application: The infectious disease market was the largest segment of the market in 2024 and accounted for 67% of the market. This is primarily driven by global vaccination programs against influenza, HPV, RSV, and COVID-19, where adjuvanted vaccines play an important role in achieving long-lasting protection, particularly for risk groups. By Administration: The intramuscular route accounted for 34% revenue share in 2024 and is expected to maintain its dominance throughout the forecast period due to a reliable immune response and ease of administration. Most presently approved vaccines, such as those used against influenza and hepatitis, are administered by the intramuscular route, also underlining its precedence. For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@ Vaccine Adjuvants Market Segmentation By Type Adjuvant emulsion Pathogen Combination Particulate Others By Administration Oral Intramuscular Intradermal Intranasal Others By Application Cancer Infectious diseases Others Regional Analysis In 2024, North America had the highest overall market share for vaccine adjuvants at 40%. There are key players, high immunization coverage, government support, and rapid approval of new adjuvants. The U.S., in particular, is commanding the market in the region on account of a well-developed clinical research infrastructure and the widespread roll-out of adjuvanted commodity vaccines. Asia Pacific is developing as the fastest-growing area due in part to rising healthcare expenditure, government-operated immunization, and the growing biotech industry in certain countries, including China, India, and South Korea. The growing incidence of communicable diseases and the demand for affordable vaccines also contribute to regional demand. Recent Developments (Vaccine Adjuvants Market) January 2024 – Vaxine has completed Phase II trials for its Advax-based RSV vaccine, demonstrating improved immunogenicity and safety. March 2024 – Croda International collaborated with Access to Advanced Health Institute (AAHI) to create novel adjuvant systems for enhanced access to vaccines worldwide. May 2023 Croda has agreed to acquire Avanti Polar Lipids to expand its lipid-based adjuvant manufacturing, while MagnumOpus inked to research partnership with the University of Copenhagen. February 2024 – Dynavax Technologies increased supply agreements for its CpG 1018 adjuvant with in‐market and COVID‐19 vaccine manufacturers globally. Table of Contents – Major Key Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 6. Competitive Landscape 7. Vaccine Adjuvants Market by Type 8. Vaccine Adjuvants Market by Administration 9. Vaccine Adjuvants Market by Application 10. Regional Analysis 11. Company Profiles 12. Use Cases and Best Practices 13. Conclusion Buy a Single-User PDF of Vaccine Adjuvants Market Analysis & Outlook Report 2024-2032@ About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
